Clinical Trial Update: A Study to Evaluating the Efficacy and Safety of Recombinant Long-acting Human Growth Hormone (TJ101) in Children With Growth Hormone Deficiency [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of recombinant long-acting human growth hormone (TJ101) in children with growth hormone deficiency has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• TJ101

Snippet

Sponsor: TJ Biopharma Co., Ltd. | Conditions: Pediatric Growth Hormone Deficiency | Phase 3 | Status: COMPLETED